Postoperative ileus: Impact of pharmacological treatment,laparoscopic surgery and enhanced recovery pathways

被引:27
作者
Knut Magne Augestad [1 ,2 ]
Conor P Delaney [1 ]
机构
[1] Division of Colorectal Surgery,University Hospitals Case Medical Center,Cleveland,OH 44106-5047,United States
[2] Department of Digestive Surgery,Telemedicine and Integrated Care,University Hospital North Norway,9037 Tromsφ,Norway
关键词
Postoperative ileus; Pathophysiology; Cost utilization; Pharmacologic treatment; Laparoscopic surgery; Enhanced recovery pathways;
D O I
暂无
中图分类号
R656.7 [小肠];
学科分类号
1002 ; 100210 ;
摘要
Almost all patients develop postoperative ileus (POI) after abdominal surgery.POI represents the single largest factor influencing length of stay (LOS) after bowel resection,and has great implications for patients and resource utilization in health care.New methods to treat and decrease the length of POI are therefore of great importance.During the past decade,a substantial amount of research has been performed evaluating POI,and great progress has been made in our understanding and treatment of POI.Laparoscopic procedures,enhanced recovery pathways and pharmacologic treatment have been introduced.Each factor has substantially contributed to decreasing the length of POI and thus LOS after bowel resection.This editorial outlines resource utilization of POI,normal physiology of gut motility and pathogenesis of POI.Pharmacological treatment,fast track protocols and laparoscopic surgery can each have significant impact on pathways causing POI.The optimal integration of these treatment options continues to be assessed in prospective studies.
引用
收藏
页码:2067 / 2074
页数:8
相关论文
共 28 条
[11]  
Alvimopan accelerates gastrointestinal recovery after bowel resection regardless of age, gender, race, or concomitant medication use[J] . Anthony J. Senagore,Joel J. Bauer,Wei Du,Lee Techner.Surgery . 2007 (4)
[12]  
Orthopedics[P]. HYLAND DANIEL F.中国专利:US2162916A,1939-06-20
[13]  
A systematic review of postoperative analgesia following laparoscopic colorectal surgery. Levy BF,Tilney HS,Dowson HM,Rockall TA. Colorectal Disease . 2010
[14]  
Alvimopan, for Postoperative Ileus Following Bowel Resection: A Pooled Analysis of Phase III Studies[J] . Conor P. Delaney,Bruce G. Wolff,Eugene R. Viscusi,Anthony J. Senagore,John G. Fort,Wei Du,Lee Techner,Bruce Wallin.Annals of Surgery . 2007 (3)
[15]  
Does Gum Chewing Ameliorate Postoperative Ileus? Results of a Prospective Randomized, Placebo-Controlled Trial[J] . Paul H. Niloff.Journal of the American College of Surgeons . 2006 (3)
[16]  
Does Gum Chewing Ameliorate Postoperative Ileus? Results of a Prospective, Randomized, Placebo-Controlled Trial[J] . Evan Matros,Flavio Rocha,Michael Zinner,John Wang,Stanley Ashley,Elizabeth Breen,David Soybel,Brent Shoji,Anne Burgess,Ronald Bleday,Richard Kuntz,Edward Whang.Journal of the American College of Surgeons . 2006 (5)
[17]  
Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery[J] . E. R. Viscusi,S. Goldstein,T. Witkowski,A. Andonakakis,R. Jan,K. Gabriel,W. Du,L. Techner,B. Wallin.Surgical Endoscopy . 2006 (1)
[18]   Systematic review of enhanced recovery programmes in colonic surgery [J].
Wind, J. ;
Polle, S. W. ;
Jin, H. P. Fung Kon ;
Dejong, C. H. C. ;
von Meyenfeldt, M. F. ;
Ubbink, D. T. ;
Gouma, D. J. ;
Bemelman, W. A. .
BRITISH JOURNAL OF SURGERY, 2006, 93 (07) :800-809
[19]  
Laparoscopic colonic surgery – mission accomplished or work in progress?[J] . H.Kehlet,R. H.Kennedy.Colorectal Disease . 2006 (6)
[20]  
Phase III Trial of Alvimopan, a Novel, Peripherally Acting, Mu Opioid Antagonist, for Postoperative Ileus After Major Abdominal Surgery[J] . Conor P. Delaney,James L. Weese,Neil H. Hyman,Joel Bauer,Lee Techner,Kathie Gabriel,Wei Du,William K. Schmidt,Bruce A. Wallin.Diseases of the Colon & Rectum . 2005 (6)